What is the recommended anesthetic management for an elderly male adult with hypertension, coronary artery disease, chronic obstructive pulmonary disease, dyslipidemia, and possible chronic kidney disease undergoing abdominal aortic aneurysm (AAA) repair?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Management for Abdominal Aortic Aneurysm Repair

For patients undergoing AAA repair with significant comorbidities including CAD, COPD, and possible CKD, the anesthetic approach should prioritize perioperative beta-blockade, careful hemodynamic monitoring with transesophageal echocardiography, and consideration of local/regional anesthesia for endovascular repair when feasible.

Preoperative Cardiac Optimization

Perioperative beta-adrenergic blocking agents are mandatory in patients with coronary artery disease undergoing AAA repair to reduce adverse cardiac events and mortality (Class I, Level A). 1 This represents the strongest evidence-based intervention to improve outcomes in this high-risk population. 2

Preoperative Cardiac Assessment

  • Patients with history of MI, angina, heart failure symptoms, or age >40 years require cardiac evaluation including electrocardiography and echocardiography. 1
  • Cardiac catheterization should be individualized based on clinical risk markers rather than routinely performed, as extensive preoperative cardiac workup contributes minimally to outcomes when intraoperative hemodynamic management is optimized. 3
  • The delay to obtain coronary angiography may be dangerous unless patients have prior coronary artery bypass graft surgery or very high likelihood of severe CAD. 1

Choice of Anesthetic Technique

For Endovascular AAA Repair (EVAR)

Local anesthesia with sedation is superior to general anesthesia for EVAR and should be the preferred approach when feasible. 1 Patients undergoing EVAR with only local anesthesia have significantly lower mortality risk compared to general anesthesia (adjusted OR 0.27; 95% CI 0.1-0.7). 1

  • General anesthesia causes loss of physiologic catecholamine responses and anesthetic-induced blood pressure depression that can lead to circulatory collapse in AAA patients. 1
  • General anesthesia has deleterious effects on inflammatory responses and temperature regulation. 1

For Open AAA Repair

General anesthesia with comprehensive monitoring is required for open repair. 1 The anesthetic technique and agents should be tailored to facilitate surgical access, perfusion techniques, and monitoring of hemodynamics and organ function (Class I, Level C). 1

Intraoperative Monitoring

Essential Monitoring Components

Transesophageal echocardiography is reasonable for all open surgical repairs of the thoracic and abdominal aorta unless specific contraindications exist (Class IIa, Level B). 1 TEE is also reasonable for endovascular procedures for monitoring, procedural guidance, and endoleak detection. 1

  • Motor or somatosensory evoked potential monitoring can be useful when data will guide therapy decisions. 1
  • Invasive arterial blood pressure monitoring is essential for beat-to-beat hemodynamic assessment. 4
  • Central venous pressure monitoring helps guide fluid management in this population with frequent cardiac and renal dysfunction. 4

Hemodynamic Management Strategy

Blood Pressure Control

Maintain tight control of arterial pulse pressure to prevent aneurysm stress while ensuring adequate organ perfusion. 5 A slow, controlled increase in arterial pulse pressure is acceptable and does not increase rupture risk when properly monitored. 5

  • Target systolic BP <130 mm Hg and diastolic BP <80 mm Hg for cardiovascular event reduction. 2
  • Avoid hypotension, low cardiac output, and hypovolemia to minimize risk of acute renal failure, which is the most important predictor of postoperative renal complications. 1
  • Preoperative hydration is essential to reduce renal complications. 1

For Ruptured AAA

Use permissive hypotension strategy maintaining systolic BP between 60-90 mm Hg (sufficient for mentation) until definitive repair to decrease bleeding rate. 1, 6 This approach is supported by trauma literature on hemorrhagic shock management. 1

Pulmonary Considerations

Patients with COPD require specific perioperative respiratory optimization. 1 History of smoking and chronic pulmonary disease are important predictors of postoperative respiratory complications. 1

  • Obtain pulmonary function tests and arterial blood gas analyses for risk stratification in patients with chronic pulmonary disease. 1
  • Administer antibiotics and bronchodilators if reversible restrictive disease or excessive sputum production is present. 1
  • Smoking cessation is advisable preoperatively. 1

Renal Protection Strategy

Preoperative renal dysfunction is the most important predictor of acute renal failure after thoracic and abdominal aortic operations. 1

  • Ensure adequate preoperative hydration. 1
  • Maintain stable hemodynamics throughout the perioperative period avoiding hypotension and low cardiac output states. 1
  • Avoid hypovolemia in the perioperative period. 1

Blood Management

Cell salvage techniques and meticulous hemostasis measures are critical for perioperative safety. 7 Patients undergoing AAA repair frequently require transfusion support, particularly in open repair. 7

  • Anticipate significant blood loss in open repair and have adequate blood products available. 3
  • Implement cell salvage protocols to reduce allogeneic transfusion requirements. 7

Special Considerations for High-Risk Patients

Patients at high surgical or anesthetic risk due to severe cardiac, pulmonary, and/or renal disease have uncertain benefit from endovascular repair (Class IIb, Level B). 1 However, EVAR with local anesthesia may offer the best risk-benefit profile in this population. 1

Risk Stratification

High-risk features include: 8

  • Severe coronary or valvular heart disease
  • Decompensated COPD
  • Severe cerebrovascular disease
  • Chronic renal failure
  • Hepatic cirrhosis with portal hypertension
  • Chronic hematologic disorders with bleeding dysfunction

Approximately one in three high-risk patients will experience serious postoperative complications, most commonly cardiac events. 8 Most patients recover after slightly prolonged hospital stays. 8

Critical Pitfalls to Avoid

  • Never induce general anesthesia in ruptured AAA without adequate resuscitation and surgical readiness, as loss of catecholamine response can cause immediate circulatory collapse. 1
  • Do not delay surgery for extensive cardiac workup unless patient has unstable or severely symptomatic heart disease requiring coronary angiography. 1, 3
  • Avoid aggressive fluid resuscitation in ruptured AAA prior to proximal control, as this increases bleeding and mortality. 1
  • Do not overlook beta-blocker administration in patients with CAD, as this is the single most evidence-based intervention to reduce perioperative mortality. 1, 2

References

Related Questions

What is the detailed pre‑operative anesthetic plan for a 70‑year‑old man with hypertension, coronary artery disease, chronic obstructive pulmonary disease, dyslipidaemia and possible chronic kidney disease undergoing elective infrarenal abdominal aortic aneurysm repair?
What is the recommended approach for CAD (Coronary Artery Disease) clearance in a patient with known 3-vessel disease (3VD) prior to repair of an endoleak type I aneurysm?
Is knee replacement surgery safe in patients with an aortic (abdominal aorta) aneurysm?
What are the lifting restrictions for a patient with an aortic aneurysm?
Is a low-dose ketamine infusion safe for a patient with an abdominal aortic aneurysm?
What is the systematic approach to evaluating and managing chronic lower extremity edema?
I am a middle‑aged adult with fibromyalgia and chronic‑fatigue syndrome, persistent sympathetic overactivity and low heart‑rate variability (RMSSD ≈40 ms) despite exercise, meditation, temperature therapy and nebivolol 5 mg; I have been taking pyridostigmine 60 mg nightly for two months—Is this an appropriate treatment, what are the long‑term side‑effects, and are there better pharmacologic options?
After completing four monthly doses of rituximab (375 mg/m²) for immune thrombocytopenia, what is the next step in management?
After completing a four‑week induction of rituximab (375 mg/m² IV weekly) for immune thrombocytopenia, what should be done next?
Which new ECG changes in an asymptomatic patient on a routine ECG indicate the need to start aspirin and clopidogrel?
What is the best medication for treating acute otitis externa?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.